March 20, 2000 ICSPP Calls for Moratorium on Psychiatric Medicating of Young Children The call for a moratorium is made in response to Hillary Clinton’s efforts to allay public concerns about the drugging of children age two to four years old. The White House announced concern today about […]
Brain Development Continues Throughout Teen Years A recent study in the Journal of the American Medical Association pointed out the danger of the escalating use of psychiatric medication in the treatment of two-to-four year olds. Editorials in the journal, as well as in the Washington Post and USA Today, […]
(Reprinted with permission of the Times Union of Albany, New York) Ritalin use splits parents, school By RICK KARLIN , Staff writer Times Union, Albany, NY Sunday, May 7, 2000 Berne — District marks parents as alleged child abusers for wanting to take their 7-year-old son off the medication Like […]
Peter R. Breggin M.D. Testimony September 29, 2000 Before the Subcommittee on Oversight and Investigations Committee on Education and the Workforce U.S. House of Representatives I appear today as Director of the International Center for the Study of Psychiatry and Psychology (ICSPP), and also on my own behalf as a […]
By Arianna Huffington December 7, 1998 (Thanks to Arianna Huffington for permission to reprint) Ten days ago (November 27, 1998) the Food and Drug Administration issued new rules that require drug companies to study a lot more thoroughly the safety and effectiveness of drugs for children. Staggering though it is […]
On June 28, 2007 more than 250 headlines around the world promised that SSRI antidepressants (such as Prozac, Paxil, Zoloft, and Celexa) are safe for pregnant mothers and their developing babies. “Mom’s Antidepressant Use Poses Little Danger to Baby,” heralded the Atlanta Journal Constitution. “Antidepressants pose low birth defect risk,” claimed Boston Globe. The New York Times ran with the Associated Press’s article titled “Antidepressants Not Big Risk for Defects.” The Wall Street Journal’s coverage was titled “Reassurance on Antidepressants in Pregnancy.” The day before the news stories broke, the Centers for Disease Control spun the news in advance with a press release headlined, “New Study Finds Few Risks of Birth Defects from Antidepressant Use During Pregnancy” (CDC Division of Media, 2007).
RECENT FDA DECISION HIGHLIGHTS ETHICAL ISSUES IN DRUG RESEARCH ON CHILDREN by Peter R. Breggin, M.D. April 21, 1998 The FDA has put the interests of drug companies and the psychiatric research establishment ahead of those of America’s children. It is time for the public and concerned professionals to take […]
Originally published in The Journal of College Student Psychotherapy, Vol. 10(2) 1995, pp. 55-72 by Peter R. Breggin, M.D. and Ginger Ross Breggin ABSTRACT. The criteria for Attention-Deficit/Hyperactivity Disorder focus on behaviors that adults find frustrating and disruptive. Conflicts between children and adults are redefined as diseases or disorders within […]